Change in the MIR Family Medicine Opposition Court INGESA 2026

Key data

Candidates for Family Medicine positions in the territories of Ceuta and Melilla should know that the court evaluating and grading their tests has changed composition. The Resolution of April 20, 2026 from INGESA modifies the resolution of November 6, 2025, which originally appointed the members of the qualifying court for this selective process.

The change does not affect the validity of actions already taken nor does it constitute a restart of the process. Its only effect is to ensure that the court remains operational and properly constituted to continue with the tests and grading.

What does this regulation establish?

This resolution modifies the composition of the qualifying court for the competitive examination in Family and Community Medicine of INGESA. Below is the complete regulatory context of the process:

The qualifying court is the central body of the selective process: it evaluates candidates' tests, resolves claims and proposes candidates who pass the process for appointment as permanent statutory personnel. Any change in its composition must be published in the BOE to ensure transparency and legal certainty of the process.

The most common cause of this type of modification is the voluntary resignation of appointed members, the emergence of supervening incompatibilities (for example, direct professional relationship with a candidate) or force majeure. The regulations require replacing the affected member so that the court maintains its regulatory composition and can continue to act validly.

Operational impact for candidates

This change has no direct economic impact for candidates. However, it has relevant operational implications that are worth knowing:

• Process continuity: Tests already taken maintain their validity. The new court assumes the process in the state it is in, without retroactivity.
• New court, same criteria: The change of members does not imply modification of the evaluation criteria or the scoring established in the March 2025 call.
• Transparency guaranteed: Publication in the BOE of the new composition allows candidates to know who will evaluate them and exercise their right of recusal if they detect any cause of incompatibility.
• No impact on deadlines: The resolution does not modify the deadlines of the selective process nor the dates of pending tests.

Who does it affect?

This resolution directly and immediately affects the following groups:

• Active candidates: All candidates participating in the competitive examination for Family and Community Medicine called by INGESA in March 2025, both through free access and internal promotion.
• Family Medicine doctors in Ceuta and Melilla: Professionals who opted for the internal promotion route to consolidate their position as permanent statutory personnel.
• INGESA human resources managers: Those responsible for administrative management of the selective process in the territories of Ceuta and Melilla.
• Advisors and preparers of healthcare opposition: Professionals who advise candidates in this specific INGESA process.

It does not affect candidates from other autonomous communities nor other selective processes of the National Health System managed by autonomous communities with transferred healthcare competencies.

Practical example

A resident physician who completed their MIR training in Family and Community Medicine and applied for the INGESA competitive examination called in March 2025 to obtain a permanent position in Ceuta is currently in the middle of the selective process.

Following the publication of this resolution on April 27, 2026, this candidate should know that:

• The court that will evaluate them from April 20, 2026 has a different composition from the one appointed in November 2025.
• The tests already taken and the grades obtained to date maintain full validity.
• They have the right to consult the new court composition in the BOE (BOE-A-2026-9119) and, if they detect any cause of incompatibility with any of the new members, they can exercise their right of recusal in accordance with administrative procedure regulations.
• They should not perform any additional management if there is no cause for recusal: the process continues normally.

What should candidates do now?

1. Consult the resolution in the BOE: Access the complete resolution (BOE-A-2026-9119) to learn the exact new composition of the court.
2. Verify possible grounds for recusal: Check if there is any professional, personal or other relationship with the new court members that could constitute grounds for incompatibility. If so, submit a recusal motion within the established deadlines.
3. Maintain preparation: The change of court does not alter the evaluation criteria or the syllabus. Continue with regular preparation.
4. Stay alert to new BOE publications: INGESA may publish additional resolutions with test dates or court actions. Monitor the BOE or activate alerts for the process reference.
5. Consult with your preparer or advisor: If there is any doubt about the impact of this change on the candidate's particular situation, consult with a professional specialized in healthcare opposition or administrative law.